(Q82265485)

English

Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial

scientific article published on October 29, 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

multicenter clinical trial

1 reference

based on heuristic

inferred from title

phase II clinical trial

1 reference

based on heuristic

inferred from title

gastric adenocarcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

perioperative period

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

author name string

L. E. Ferri

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

S. Ades

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

T. Alcindor

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

M. Chasen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

V. Marcus

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

M. Hickeson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

G. Artho

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

M. P. Thirlwell

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22039085

16 December 2024

publication date

29 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

full work available at URL

http://www.annalsofoncology.org/article/S0923753419387083/pdf

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22039085

16 December 2024

https://api.elsevier.com/content/article/PII:S0923753419387083?httpAccept=text/xml

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

https://api.elsevier.com/content/article/PII:S0923753419387083?httpAccept=text/plain

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

http://academic.oup.com/annonc/article-pdf/23/6/1512/401423/mdr465.pdf

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1512-1517

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study

1

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Two thousand transhiatal esophagectomies: changing trends, lessons learned.

2

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Treatment outcomes of resected esophageal cancer

3

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Extended lymph-node dissection for gastric cancer

4

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

5

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

6

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors

7

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

8

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

9

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

10

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

11

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Optimal two-stage designs for phase II clinical trials

12

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

An unusual case of a strangulated lung hernia after an Ivor Lewis esophagectomy

13

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

14

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome

15

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group

16

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

17

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

The management of dysphagia in esophageal cancer patients undergoing neoadjuvant chemotherapy: Is invasive tube feeding required?

18

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

19

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies

20

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma

21

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients

22

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

23

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

24

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

25

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy

26

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma

27

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review

28

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer

29

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer

30

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma.

31

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

32

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Nodal dissection for patients with gastric cancer: a randomised controlled trial

33

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma

34

1 reference

10.1093/ANNONC/MDR465

https://api.crossref.org/works/10.1093/ANNONC/MDR465

16 December 2024

Identifiers

10.1093/ANNONC/MDR465

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22039085%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82265485&oldid=2288050713"